This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
48 |
4. Check minimum number of eventsNone |
48 |
5. Include endpointsNone |
48 |
6. Filter based on genotype QC (FinnGen only) |
48 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Alport
based on the number of shared cases.
Similar with more cases:
- Other specified congenital malformation syndromes affecting multiple systems
- Exclusion endpoint for clefts
- Clefts and syndromes for tooth agenesis exclusion, including avohilmo
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 48 | 20 | 28 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 24.94 | 21.30 | 27.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
32
30
30.00
33.31
16.0
7.3
mmol/l
11.9
6.3
3.68
32
30
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
24
16
29.00
29.20
9.0
12.9
mg/l
1.9
1.3
0.99
24
16
(3000991) Gas panel - Venous blood
27
31
18.62
24.05
12.4
6.8
—
—
—
0
0
(3012544) pH of Venous blood
27
39
14.54
20.20
9.7
7.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
28
51
11.78
17.19
6.2
2.7
e6/l
1.3
1.1
0.09
18
32
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
56
11.56
16.93
5.8
2.7
e6/l
0.4
0.6
0.22
18
37
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
19
14.56
16.29
4.9
1.5
ml/min/173m2
42.4
71.3
—
8
8
(3030467) Casts [#/volume] in Urine by Automated count
35
89
11.83
15.96
10.8
2.6
e6/l
0.0
0.2
1.18
30
74
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
40
113
16.13
15.61
11.8
2.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
34
91
10.38
14.50
10.4
2.8
mmol/l
7.1
9.1
1.81
34
79
(36304419) Bacteria [Presence] in Urine
34
93
10.11
14.13
9.9
2.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
33
88
9.80
14.02
21.5
3.1
ph
7.3
7.4
—
5
12
(3024561) Albumin [Mass/volume] in Serum or Plasma
37
128
9.25
11.66
12.5
5.0
g/l
35.9
37.8
1.49
37
123
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
17
27
9.20
11.12
12.1
10.1
mmol/l
24.0
25.1
0.40
17
27
(40768446) Kidney Pathology biopsy report
10
0
+∞
10.81
1.9
0.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
27
80
6.43
9.57
5.4
3.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
39
167
8.09
9.35
8.1
2.8
estimate
0.0
0.0
—
8
35
(3009261) Glucose [Presence] in Urine by Test strip
39
168
8.02
9.06
8.1
3.0
estimate
0.0
0.0
—
9
33
(3021601) Nitrite [Presence] in Urine by Test strip
39
168
8.02
9.06
12.2
4.0
estimate
0.0
0.0
—
9
35
(3015736) pH of Urine
34
132
6.40
8.71
6.4
2.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
0
+∞
8.58
7.3
0.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
33
133
5.74
7.86
5.1
2.5
nmol/l
68.6
67.9
0.06
33
123
(3027945) Reticulocytes/100 erythrocytes in Blood
16
34
6.56
7.83
2.8
4.9
%
2.1
1.6
0.69
16
34
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
14
8.76
6.98
3.6
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
14
8.76
6.98
3.6
1.6
—
—
—
0
0
(4035726)
11
19
7.21
6.43
1.5
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
42
242
6.86
6.36
13.6
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
26
5.82
5.61
2.8
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
26
5.82
5.61
2.7
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
15
40
5.00
5.60
3.0
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
8
13.46
5.55
1.3
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
8
13.46
5.55
1.3
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
22
81
4.17
5.45
6.0
5.6
%
103.2
92.4
1.00
22
81
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
13
33
5.03
5.10
9.1
3.3
mmol/l
1.4
1.6
0.06
13
21
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
10
10.74
5.03
8.7
9.6
%
1.1
2.9
—
9
10
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
7
13.36
4.98
1.0
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
29
5.18
4.96
7.0
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
28
129
3.81
4.93
10.9
9.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
34
180
4.05
4.83
15.6
10.0
e9/l
0.0
0.0
0.00
25
147
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
5
16.02
4.73
1.7
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
8
11.68
4.71
2.0
3.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
31
160
3.65
4.46
8.3
2.7
ug/l
197.2
82.2
0.67
31
154
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
13
8.22
4.39
2.7
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
13
8.22
4.39
2.6
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
10
9.32
4.24
2.8
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
11
8.46
4.04
8.3
7.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
15
7.10
4.03
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
15
7.10
4.03
3.0
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
40
265
4.05
3.97
14.8
7.3
u/l
88.4
81.7
0.28
40
254
(3015377) Calcium [Moles/volume] in Serum or Plasma
20
83
3.42
3.97
6.4
2.3
mmol/l
2.3
2.3
0.36
20
77
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
35
4.24
3.91
2.9
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
30
4.46
3.89
4.9
2.9
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
8
13
7.13
3.67
11.6
5.3
%
90.4
91.6
—
8
13
(3023368) Bacteria identified in Blood by Culture
17
70
3.21
3.34
8.8
4.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
19
84
3.09
3.32
4.4
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
17
5.42
3.07
3.0
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
9
22
4.78
3.06
8.0
3.4
kpa
9.6
9.9
—
9
22
(3034860) Kappa light chains.free [Mass/volume] in Serum
5
5
10.94
3.04
1.0
2.4
mg/l
67.3
31.8
—
5
5
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
5
5
10.94
3.04
1.0
2.4
mg/l
58.1
27.2
—
5
5
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
21
104
2.81
2.94
2.7
2.5
u/l
79.0
54.9
0.92
21
99
(3022096) Basophils/100 leukocytes in Blood
30
180
2.78
2.89
13.1
8.5
%
0.6
0.7
0.18
30
168
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
24
4.36
2.84
2.6
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
33
212
2.78
2.72
3.8
2.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
11
6.05
2.63
1.0
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
18
87
2.71
2.59
8.4
3.0
estimate
0.0
0.0
—
9
33
(3006315) Basophils [#/volume] in Blood
31
196
2.64
2.59
12.7
8.9
e9/l
0.0
0.0
0.04
24
175
(3006504) Eosinophils/100 leukocytes in Blood
30
187
2.61
2.58
13.2
8.5
%
3.4
3.3
0.09
30
174
(3001604) Monocytes [#/volume] in Blood
31
197
2.62
2.55
12.7
8.8
e9/l
0.6
0.6
0.67
24
175
(3019069) Monocytes/100 leukocytes in Blood
30
190
2.54
2.45
13.2
8.6
%
9.1
8.1
1.84
30
181
(3042936) Bacteria identified in Isolate by Culture
12
48
3.00
2.41
1.8
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
31
201
2.53
2.39
14.2
9.4
e9/l
0.2
0.2
0.25
24
182
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
17
83
2.62
2.38
3.3
2.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
31
205
2.45
2.23
12.8
8.6
e9/l
1.9
2.0
0.24
24
186
(3018010) Neutrophils/100 leukocytes in Blood
30
196
2.41
2.21
12.5
8.1
%
55.9
54.4
0.31
30
186
(3002030) Lymphocytes/100 leukocytes in Blood
30
197
2.39
2.17
13.2
8.2
%
29.6
30.5
0.15
30
187
(3044640) Blood type and Crossmatch panel - Blood
20
110
2.40
2.16
3.1
2.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
7
20
3.91
2.15
1.7
4.0
g/l
64.3
67.6
—
7
20
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
9
32
3.22
2.13
2.4
4.2
g/l
0.3
0.2
—
9
32
(3041096) Erythrocytes [Presence] in Urine by Automated
18
97
2.37
2.01
8.8
2.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
14
69
2.45
1.88
5.8
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
7
24
3.23
1.80
1.6
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
17
95
2.22
1.71
5.2
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
14
3.85
1.66
8.4
4.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
42
349
2.62
1.60
7.0
3.4
mmol/l
4.6
4.7
0.26
42
337
(3004588) Protein electrophoresis panel - Serum or Plasma
5
15
3.59
1.56
1.4
2.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
20
124
2.05
1.53
1.4
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
21
133
2.03
1.52
9.1
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
17
100
2.08
1.49
2.2
1.7
pmol/l
110.7
96.3
—
7
53
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
42
352
2.54
1.45
7.0
3.6
mmol/l
2.7
2.9
0.39
42
340
(3013650) Neutrophils [#/volume] in Blood by Automated count
31
230
1.98
1.39
15.0
12.0
e9/l
3.8
4.0
0.19
24
204
(3007853) Bacteria identified in Skin by Aerobe culture
10
48
2.37
1.39
1.6
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
41
340
2.41
1.38
6.1
3.1
mmol/l
1.4
1.3
0.28
41
326
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
41
349
2.20
1.23
7.0
3.3
mmol/l
1.3
1.4
1.04
41
336
(4010399)
5
20
2.67
1.18
1.6
1.3
—
—
—
0
0
(3019225) pH of Specimen
5
20
2.67
1.18
15.0
5.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
109
1.87
1.14
8.5
9.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
18
118
1.84
1.12
2.1
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
20
137
1.79
1.08
2.4
3.4
u/l
28.4
30.6
0.24
20
129
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
121
1.78
1.02
4.9
2.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
32
0.00
0.99
0.0
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
27
2.39
0.97
16.7
2.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
28
2.30
0.95
1.3
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
25
0.00
0.81
0.0
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
38
329
1.74
0.76
5.9
3.1
mmol/l
5.6
5.7
0.25
38
315
(3000494) Fungus identified in Specimen by Culture
7
43
1.73
0.70
1.1
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
11
72
1.68
0.66
1.8
3.1
mg/l
0.9
0.8
0.07
11
57
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
39
348
1.64
0.63
3.9
3.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
85
0.54
0.63
3.2
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
20
0.00
0.62
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
20
0.00
0.62
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
20
0.00
0.62
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
20
0.00
0.62
0.0
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
19
0.00
0.62
0.0
1.3
—
4.0
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
19
0.00
0.62
0.0
1.2
—
0.2
—
0
12
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
21
0.00
0.61
0.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
42
385
1.73
0.60
35.9
11.4
%
36.8
41.2
4.21
37
330
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
21
168
1.44
0.53
3.8
4.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
45
1.65
0.52
1.1
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
41
378
1.58
0.45
36.6
13.8
g/l
331.3
335.9
2.33
41
378
(3005033) Fetal Nuchal fold Thickness US
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
8.5
—
0
12
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
30
331
0.75
0.35
5.5
4.4
mu/l
1.9
1.8
0.15
30
316
(40768797) Stomach Pathology biopsy report
5
39
1.31
0.24
1.2
1.3
—
—
—
0
0
(4034850)
0
11
0.00
0.21
0.0
7.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
4.6
—
4.5
—
0
11
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
4.7
—
439.6
—
0
11
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
4.4
—
3.4
—
0
12
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
4.4
—
344.2
—
0
12
(3023511) Choriogonadotropin [Units/volume] in Urine
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(4306422)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
10
87
1.19
0.10
3.2
3.9
ug/l
2.5
1.5
—
10
82
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
60
0.81
0.09
1.6
1.3
—
—
—
0
0
(3013512) EKG study
7
67
1.05
0.08
5.9
3.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
74
1.10
0.08
2.5
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
13
141
0.89
0.06
3.5
2.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
26
269
0.93
0.03
4.7
3.5
mm/h
18.8
7.2
2.25
26
255
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
116
0.93
0.01
1.6
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
28
282
0.98
0.00
4.5
3.8
pmol/l
14.8
14.9
0.06
28
268
(36660697) Celiac disease serology panel - Serum
6
59
1.02
0.00
1.0
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
1.7
—
0
7
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.5
—
0
5
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
7
0.00
0.00
0.0
6.9
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
51.0
—
0
7
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
84
0.94
0.00
12.1
5.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
1.4
—
0
5
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
1.0
—
13.2
—
0
5
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_ALPORT – Alport
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).